Cilostazol Following Peripheral Endovascular Procedures

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT02770274

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02770274
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Greece (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02770274. Randomized; single masking; primary purpose prevention. Start 2016-12 (actual); primary completion 2021-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cilostazol Following Peripheral Endovascular Procedures
Acronym
CILO-PER
Condition
Peripheral Arterial Disease
Intervention (Drug)
Cilostazol
Intervention (Drug)
Aspirin
Lead sponsor
Attikon Hospital (class: other)
Collaborator
University Hospital of Patras (class: other)

Record details

Record id
cardio:ct-nct02770274
Content hash
ec1eb5496dbda4ceafab153470090c2690e2c23563fcbf35ca32c95f7eef9899